Clinical Trials Browser

Amyloidosis, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Basal Cell, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Glioblastoma, Carcinoma, Hepatocellular, Hodgkin Disease, Lung Neoplasms, Melanoma, Multiple Myeloma, Myelodysplastic Syndromes, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Endometrial Neoplasms, Lymphoma, Mantle-Cell

NCT07591597 2026-05-18

IGNITE-CRC

Phase 1/2 Not yet recruiting

68 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT07592338 2026-05-18

KITuKo

Completed

30 enrolled

Gastrointestinal

Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT07594067 2026-05-18

TCR1188-ABC Cells in KRAS-mutated Cancers

Phase 1 Not yet recruiting

30 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Cholangiocarcinoma

NCT04406714 2026-05-15

SCORE

Phase NA Completed

4,318 enrolled 18 charts

Gastrointestinal

Colorectal Neoplasms

NCT04776837 2026-05-15

Predicting Disease Progression and/or Recurrence in Cancer

Completed

159 enrolled

Gastrointestinal

Biliary Tract Neoplasms, Esophageal Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Colorectal Neoplasms, Disease Progression

NCT04921488 2026-05-15

IA COLO

Phase NA Completed

194 enrolled

Gastrointestinal

Intestinal Polyps, Colorectal Neoplasms

NCT05056896 2026-05-15

ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension

Phase EARLY_PHASE1 Active not recruiting

161 enrolled 9 charts

Gastrointestinal

Colorectal Neoplasms

Clinical Trials

Bridge CRC

ASPIRES

Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients

Microbial and Environmental Factors Associated With Polyps Development in Familial Adenomatous Polyposis (MicrobEnvironment in FAP)

Tumor Deposits in Colorectal Cancer and Its Prognostic Value in Survival and Metastasis

Role of Diet on the Microbiome of the Digestive System

Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab in the Treatment of Metastatic BRAF-mutated Colorectal Cancer Refractory

CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors

COFRUQ

PACHA-02

X-CLOSURE

FORBES

Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer

Acupuncture Pilot Study for Cancer-related Cognitive Function

Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer

TRIBE-C

Time-restricted Eating Versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers

VERDI

Liver Transplantation for Non-resectable Colorectal Liver Metastases: Translational Research

Cadonilimab for PD-1/PD-L1 Blockade-refractory, MSI-H/dMMR, Advanced Colorectal Cancer

NEST-1

Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.

Precision-MRD: Prospective Observational Study of Biomarker-directed Systemic Therapy for Colorectal Cancer Patients With Minimal Residual Disease

PICC-3

A Phase II Randomized Trial of Serplulimab With Second-Line Chemo/Targeted Therapy for Early Relapse Colorectal Cancer After Adjuvant Chemotherapy

RILUZOX-01

PARERE

Dose Escalation and Expansion Study of TROP2 CAR Engineered IL-15- Transduced Cord Blood-derived NK Cells in Combination With Cetuximab in Patient With Colorectal Cancer (CRC) With Minimal Residual Disease (MRD)

PACE

Evaluation of Colonic Perfusion by Indocyanine Green Angiography During Colorectal Surgery

Phase II Study of Anti-PD-1/VEGF Bispecific Antibody Ivonescimab in Patients With Previously Treated Metastatic Colorectal Cancer

Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal Cancer

Intraoperative Use of Oxygen Saturation Imaging to Assess Intestinal Perfusion

NUTRICOLOR

Evaluation of Fecal Multi-target Biomarkers in the Screening of Digestive Tract Cancers

Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery

OxaNeuro

AL

COLIBRI-GI

POD Risk for Colorectal Cancer Surgery

A Study of DCTY1102 Injection in Participants With Advanced Solid Tumors

BILMOD

The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas

IGNITE-CRC

KITuKo

TCR1188-ABC Cells in KRAS-mutated Cancers

SCORE

Predicting Disease Progression and/or Recurrence in Cancer

IA COLO

ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension